Chesler David A, Berger Mitchell S, Quinones-Hinojosa Alfredo
Department of Neurosurgery, University of Maryland Medical Center, Baltimore, MD 21212, USA.
Front Biosci (Schol Ed). 2012 Jan 1;4(1):190-205. doi: 10.2741/S261.
Despite intensive clinical and laboratory research and effort, Glioblastoma remains the most common and invariably lethal primary cancer of the central nervous system. The identification of stem cell and lineage-restricted progenitor cell populations within the adult human brain in conjunction with the discovery of stem-like cells derived from gliomas which are themselves tumorigenic and have been shown to have properties of self-renewal and multipotency, has led to the hypothesis that this population of cells may represent glioma initiating cells. Extensive research characterizing the anatomic distribution and phenotype of neural stem cells in the adult brain, and the genetic underpinnings needed for malignant transformation may ultimately lead to the identification of the cellular origin for glioblastoma. Defining the cellular origin of this lethal disease may ultimately provide new therapeutic targets and modalities finally altering an otherwise bleak outcome for patients with glioblastoma.
尽管进行了深入的临床和实验室研究与努力,但胶质母细胞瘤仍然是中枢神经系统最常见且始终致命的原发性癌症。在成人大脑中鉴定出干细胞和谱系受限的祖细胞群体,同时发现源自胶质瘤的类干细胞,这些细胞本身具有致瘤性,并已显示出自我更新和多能性的特性,这导致了一种假说,即这群细胞可能代表胶质瘤起始细胞。广泛的研究对成人大脑中神经干细胞的解剖分布和表型以及恶性转化所需的遗传基础进行了表征,最终可能会确定胶质母细胞瘤的细胞起源。确定这种致命疾病的细胞起源最终可能会提供新的治疗靶点和方式,最终改变胶质母细胞瘤患者原本黯淡的预后。